Infectious Diseases
Research Examines High-Risk Children and COVID-19
New data show certain children at higher risk for hospitalization and severe disease.
Facts on Vaccine Decision Examined by People with IDD and their Families
Videos acknowledge concerns and respect the decision-making power of people with disabilities.
COVID-19 Prophylaxis Developed in Record Time
Experience fueled monoclonal antibody development in under a month.
Penicillin Allergy Record Is a Fossil for Many Adults
Ongoing study demonstrates majority flagged can safely receive penicillin.
Platelets Act as First Responders to COVID-19 and Flu
Heart attack and stroke risks rise as cells respond to respiratory infections.
New Technique Uncovers Antibodies for Viral Pathogens
High-throughput approach reveals ultrapotent candidate with efficacy against SARS-CoV-2 variants.
Lessons Learned on Tobacco During the Pandemic
Pattern shifts could inform future evidence-based addiction interventions.
Holistic Support for COVID-19 Long-haulers
Providers share best means of helping survivors recover from trauma, cognitive injury.
Large-scale Data Emerges on COVID-19 Hospitalizations
Head of Vanderbilt-led study discusses ongoing research to evaluate SARS-CoV-2 vaccines.
Respiratory Microbiome May Impact COVID-19 Severity
New study will detail role of upper respiratory tract bacteria in susceptibility to SARS-CoV-2.
Facing Down COVID-19 at Every Level
From drug discovery to health equity, Vanderbilt joins worldwide leaders to conquer the pandemic.